Valar Labs, which has developed AI models to help predict bladder cancer treatment outcomes, raised a $22M Series A led by DCVC and a16z — Putting AI to work in the healthcare industry is a tricky business; it's even more so in oncology, where the stakes are especially high.
Posted from: this blog via Microsoft Power Automate.
